Anti–Gamma Aminobutyric Acid B Autoimmune Encephalitis in an Indian Child with Early-Onset Seizures, Neurodegeneration, and Brain Calcification due to NRROS Variation: The First Reported Case Worldwide

Abstract

A 1.5-year-old boy presented to us with a history of normal growth and developmental parameters until 6 months of age. However, at 7 months of age, he developed multiple types of seizures consisting initially of complex febrile seizures, followed by afebrile seizures. Multifocal clonic, generalized tonic–clonic, and myoclonic (multifocal and generalized) were the evolving seizure types. He had truncal hypotonia, but his appendicular hypotonia progressed to hypertonia over the next few months and further to decorticate posturing. Brain magnetic resonance imaging (MRI) showed generalized atrophy, predominantly frontotemporal, without any focal signal abnormalities or contrast enhancement. Computed tomography (CT) showed speckled calcification in subcortical white matter. Electroencephalogram showed bilateral frontotemporal epileptiform discharges with secondary generalization. His cerebrospinal fluid had normal cytology and biochemical results but was positive for anti–gamma aminobutyric acid B antibodies. Whole exome sequencing showed likely pathogenic, novel autosomal recessive homozygous variation of NRROS gene on chromosome 3 [c.1487G > A (p.Trp496Ter)], which impairs the functioning of anti-inflammatory cytokine transforming growth factor beta, resulting in a proinflammatory state within the central nervous system and thereby promoting autoimmune encephalitis. Parental Sanger sequencing validated the variation in both his parents. He was treated with both pulse methylprednisolone (30 mg/kg/day for 5 days) and intravenous immunoglobulin (2 g/kg), followed by slowly tapering of oral prednisolone and monthly intravenous immunoglobulin infusion (1 g/kg). There was significant reduction in seizure frequency and disappearance of epileptiform discharges from the electroencephalogram. However, the motor and cognitive improvement did not occur, and he had microcephaly and growth failure at the last follow-up. This is the 11th case report of neurodegeneration associated with NRROS gene variations, but the first report of autoimmune encephalitis being triggered by the variation in a child.

Keywords

microglia - NRROS - SENEBAC - autoimmune encephalitis - TGF-β

Publication History

Received: 04 August 2022

Accepted: 20 September 2022

Article published online:
09 November 2022

• References

• 1 Prinz M, Masuda T, Wheeler MA, Quintana FJ. Microglia and central nervous system-associated macrophages-from origin to disease modulation. Annu Rev Immunol 2021; 39: 251-277
• 2 Smith C, McColl BW, Patir A. et al. Biallelic mutations in NRROS cause an early onset lethal microgliopathy. Acta Neuropathol 2020; 139 (05) 947-951
• 3 Noubade R, Wong K, Ota N. et al. NRROS negatively regulates reactive oxygen species during host defence and autoimmunity. Nature 2014; 509 (7499): 235-239
• 4 Dong X, Tan NB, Howell KB. et al. Bi-allelic LoF-NRROS variants impairing active TGF-beta-1 delivery cause a severe infantile-onset neurodegenerative condition with intracranial calcification. Am J Hum Genet 2020; 106 (04) 559-569
• 5 Leavy O. Inflammation: regulating ROS. Nat Rev Immunol 2014; 14 (06) 357
• 6 Macintosh J, Derksen A, Poulin C. et al. Novel biallelic variants in NRROS associated with a lethal microgliopathy, brain calcifications, and neurodegeneration. Neurogenetics 2022; 23 (02) 151-156
• 7 Zhang J, Buller BA, Zhang ZG. et al. Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system. Exp Neurol 2022; 347: 113895
• 8 Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 2017; 35: 441-468
• 9 Nguyen HM, Grössinger EM, Horiuchi M. et al. Differential Kv1.3, KCa3.1, and Kir2.1 expression in “classically” and “alternatively” activated microglia. Glia 2017; 65 (01) 106-121
• 10 Qin Y, Garrison BS, Ma W. et al. A milieu molecule for TGF-β required for microglia function in the nervous system. Cell 2018; 174 (01) 156-171.e16
• 11 Du RH, Sun HB, Hu ZL, Lu M, Ding JH, Hu G. Kir6.1/K-ATP channel modulates microglia phenotypes: implication in Parkinson's disease. Cell Death Dis 2018; 9 (03) 404
• 12 Bakunina N, Pariante CM, Zunszain PA. Immune mechanisms linked to depression via oxidative stress and neuroprogression. Immunology 2015; 144 (03) 365-373
• 13 Zhu F, Shan W, Lv R, Li Z, Wang Q. Clinical characteristics of anti-GABA-B receptor encephalitis. Front Neurol 2020; 11: 403
• 14 Premakumari NS, Rudrappa S, Patagar PM. Paediatric anti-GABAB receptor encephalitis associated with SARS-CoV-2 (COVID- 19) infection. Int J Contemp Pediatrics 2021; 8: 1909-1913
• 15 Kruer MC, Hoeftberger R, Lim KY. et al. Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: the first pediatric case of γ-aminobutyric acid type B receptor autoimmunity. JAMA Neurol 2014; 71 (05) 620-623
• 16 Abound H, Probasco JC, Irani S. et al. Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 2021; 92 (07) 757-768
• 17 Häußler V, Daehn T, Rissiek B. et al. Intravenous immunoglobulin (IVIg) induce a protective phenotype in microglia preventing neuronal cell death in ischaemic stroke. Neuromolecular Med 2020; 22 (01) 121-132